USPTO serial 79426232
CELLNAP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 6, 2026
- Examiner
- MORRIS, KRISTINA KLOIBER
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CELLNAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shoko Naruo
Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biological preparations used in industry and science; biological preparations for use in industry and science; biochemical preparations for industrial and scientific purposes; chemical and biological goods, preparations, articles, substances, media and reagents for scientific use, commercial use and for use in laboratories, namely, reagents and solutions for cell handling, separation and preparation for laboratory research purposes for non-medical purposes; chemical and biological goods, preparations, articles, substances, media and reagents for scientific use, commercial use and for use in laboratories, namely, buffer solutions for cell culture for non-medical purposes; chemical and biological goods, preparations, articles, substances, media and reagents for scientific use, commercial use and for use in laboratories, namely, serum-free, chemically defined, animal component-free and xeno-free aqueous solutions in the field of cell cultures for non-medical purposes; chemical and biological goods, preparations, articles, substances, media and reagents for scientific use, commercial use and for use in laboratories, namely, nutrient media, namely, aqueous solutions for cell culture for non-medical purposes; media for cell culture, tissue, biological materials and organisms for non-medical use, namely, culture media for cultivating cells, animal and human tissue, and microorganism cells other than for medical or veterinary use; media for cell culture, tissue, biological materials and organisms for scientific use, commercial use and for use in laboratories , namely, culture media for cultivating cells, animal and human tissue, and microorganism cells other than for medical or veterinary use; growth media for cells, tissue, biological materials and organisms for scientific use and commercial use, namely, growth media for cultivating cells, animal and human tissue, and microorganism cells other than for medical or veterinary use; media for freezing cells, tissue, biological materials and organisms and cell cultures for non-medical use, namely, cryogenic preparations in solid, liquid or gas state for use in chilling and freezing; freezing media for non-medical use , namely, cryogenic preparations in solid, liquid or gas state for use in chilling and freezing | ACTIVE | — |
| 005 | Chemical and biological preparations for medical, biomedical, therapeutic, diagnostic and veterinary use for nurturing, freezing, preserving, growing or differentiating cells or human or animal tissue for medical or veterinary purposes; biological preparations for medical, biomedical, therapeutic, diagnostic and veterinary use, namely, biological reagents for medical and veterinary use; chemical and biological goods, preparations, articles, substances, media and reagents for medical, biomedical, therapeutic, diagnostic and veterinary use and for use in medical laboratories, namely, reagents and solutions for cell handling, separation and preparation for medical or veterinary purposes; chemical and biological goods, preparations, articles, substances, media and reagents for medical, biomedical, therapeutic, diagnostic and veterinary use and for use in medical laboratories, namely, buffer solutions for cell culture for medical or veterinary purposes; chemical and biological goods, preparations, articles, substances, media and reagents for medical, biomedical, therapeutic, diagnostic and veterinary use and for use in medical laboratories, namely, serum-free, chemically defined, animal component-free and xeno-free aqueous solutions for application in the field of cell cultures for medical or veterinary purposes; chemical and biological goods, preparations, articles, substances, media and reagents for medical, biomedical, therapeutic, diagnostic and veterinary use and for use in medical laboratories, namely, nutrient media, namely, aqueous solutions for cell culture for medical or veterinary purposes; chemical and biological goods, preparations, articles, substances, media and reagents for medical, biomedical, therapeutic, diagnostic and veterinary use and for use in laboratories, namely, biological tissue cultures culture biological reagents for medical and veterinary use; media for cell culture, tissues, biological materials and organisms for medical, therapeutic, diagnostic and veterinary use, namely, media for cultivating cells, animal and human tissue, and microorganism cells for medical and veterinary use; nutritional media for cells, tissues, biological materials and organisms for medical, therapeutic, diagnostic and veterinary use, namely, cell growth media for growing cells for medical and veterinary use; media for freezing cells, tissues, biological materials, organisms and cell cultures for medical, therapeutic, diagnostic and veterinary use, namely, cryopreservation aqueous solution for use in in vitro fertilization consisting primarily of reproductive cells freezing medium, cryopreservation aqueous solution for medical and veterinary use; freezing media for medical, biomedical, therapeutic, diagnostic and veterinary use, namely, cryopreservation aqueous solution for use in medical or veterinary procedures, cryopreservation aqueous solution for use in preparations of cells for medical or veterinary procedures | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 6, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 18, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 13, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 12, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 29, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 29, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 20, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 20, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 20, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 20, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 20, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 17, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 17, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 17, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 5, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 20, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 20, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 1, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 30, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2025 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Sep 23, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 8, 2025 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jun 20, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 20, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 19, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |